Project Description

“Performance” Based DIR Fees: A Rigged System with Disparate Effect on Specialty Pharmacies, Medicare Part D Beneficiaries and the U.S. Healthcare System

“Performance” Based DIR Fees: A Rigged System with Disparate Effect on Specialty Pharmacies, Medicare Part D Beneficiaries and the U.S. Healthcare System, commissioned by National Association of Specialty Pharmacy (NASP) and authored by the law firm, Frier Levitt, LLC. This white paper focuses on percentage-based DIR fees which are often shrouded by PBMs under the aegis of “performance.”

Read Full Study Here >>